Paragraph 26ZA Status of certain UK marketing authorisations granted before IP completion dayF1

(1)

This paragraph applies in relation to a UK marketing authorisation granted by the licensing authority under Chapter 4 of Title III to the 2001 Directive that was in force immediately before IP completion day.

(2)

A UK marketing authorisation to which this paragraph applies—

(a)

has effect on and after IP completion day as a UKMA(UK) granted under regulation 49(1) of these Regulations; and

(b)

is treated as including a statement that it is in force in the whole United Kingdom for the purposes of regulation 49(1C).

Annotations

Textual amendments

F1: Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)